PlainRecalls
FDA Drug Moderate Class II Terminated

Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11

Reported: October 31, 2018 Initiated: September 19, 2018 #D-0280-2019

Product Description

Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11

Reason for Recall

Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

Details

Units Affected
44,764 bottles
Distribution
Nationwide USA, Puerto Rico and Guam
Location
Maple Grove, MN

Frequently Asked Questions

What product was recalled?
Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11. Recalled by Upsher Smith Laboratories, Inc.. Units affected: 44,764 bottles.
Why was this product recalled?
Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 31, 2018. Severity: Moderate. Recall number: D-0280-2019.